Search research articles
Contact Us
Filters
Showing results (91-100 of 103) with videos related to
Page
of 11
Sort By:
Pharmacological Research
|
June 28, 2024
Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches
Kexin Cai, Haoyue Jiang, Yuanming Zou, et al.
JAMA Cardiology
|
June 18, 2024
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension: A Randomized Clinical Trial
Xiaofan Guo, Nanxiang Ouyang, Guozhe Sun, et al.
BMC Medicine
|
June 20, 2024
Impact of baseline cardiovascular risk on the outcomes of intensive blood pressure intervention: a post hoc analysis of the China rural hypertension control project
Guozhe Sun, Chang Wang, Ning Ye, et al.
Cell Research
|
July 13, 2023
α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
Naijin Zhang, Ying Zhang, Jiaqi Xu, et al.
Journal of the American College of Cardiology
|
July 8, 2026
Cardiovascular Health Change Patterns After Multifaceted Antihypertensive Intervention and Cardiovascular Outcomes: A Post Hoc Analysis of CRHCP Trial
Xiaofan Guo, Guozhe Sun, Ziyi Xie, et al.
China CDC Weekly
|
July 7, 2025
Hypertension Control in China: Translation from Clinical Trial to Real-World Application - Preliminary Outcomes
Guozhe Sun, Hao Peng, Songyue Liu, et al.
Lancet (London, England)
|
March 5, 2023
Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial
Jiang He, Nanxiang Ouyang, Xiaofan Guo, et al.
BMC Medicine
|
March 3, 2026
Cardiovascular outcomes of intensive blood pressure control in patients with and without metabolic dysfunction-associated fatty liver disease: post hoc analysis of the CRHCP trial
Songyue Liu, Yangzhi Yin, Hongmei Yang, et al.
Lancet (London, England)
|
September 3, 2025
Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials
Xiaofan Guo, Guozhe Sun, Yu Xu, et al.
JAMA Network Open
|
February 13, 2026
Intensive Blood Pressure Control and Cardiovascular Outcomes Across Cardiovascular-Kidney-Metabolic Syndrome Stages: A Post Hoc Analysis of the China Rural Hypertension Control Project
Xiaofan Guo, Shiyu Zhou, Jianjun Mu, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 103) with videos related to
Sort By:
Page
of 11
Pharmacological Research
|
June 28, 2024
Programmed death of cardiomyocytes in cardiovascular disease and new therapeutic approaches
Kexin Cai, Haoyue Jiang, Yuanming Zou, et al.
JAMA Cardiology
|
June 18, 2024
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension: A Randomized Clinical Trial
Xiaofan Guo, Nanxiang Ouyang, Guozhe Sun, et al.
BMC Medicine
|
June 20, 2024
Impact of baseline cardiovascular risk on the outcomes of intensive blood pressure intervention: a post hoc analysis of the China rural hypertension control project
Guozhe Sun, Chang Wang, Ning Ye, et al.
Cell Research
|
July 13, 2023
α-myosin heavy chain lactylation maintains sarcomeric structure and function and alleviates the development of heart failure
Naijin Zhang, Ying Zhang, Jiaqi Xu, et al.
Journal of the American College of Cardiology
|
July 8, 2026
Cardiovascular Health Change Patterns After Multifaceted Antihypertensive Intervention and Cardiovascular Outcomes: A Post Hoc Analysis of CRHCP Trial
Xiaofan Guo, Guozhe Sun, Ziyi Xie, et al.
China CDC Weekly
|
July 7, 2025
Hypertension Control in China: Translation from Clinical Trial to Real-World Application - Preliminary Outcomes
Guozhe Sun, Hao Peng, Songyue Liu, et al.
Lancet (London, England)
|
March 5, 2023
Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial
Jiang He, Nanxiang Ouyang, Xiaofan Guo, et al.
BMC Medicine
|
March 3, 2026
Cardiovascular outcomes of intensive blood pressure control in patients with and without metabolic dysfunction-associated fatty liver disease: post hoc analysis of the CRHCP trial
Songyue Liu, Yangzhi Yin, Hongmei Yang, et al.
Lancet (London, England)
|
September 3, 2025
Benefit-harm trade-offs of intensive blood pressure control versus standard blood pressure control on cardiovascular and renal outcomes: an individual participant data analysis of randomised controlled trials
Xiaofan Guo, Guozhe Sun, Yu Xu, et al.
JAMA Network Open
|
February 13, 2026
Intensive Blood Pressure Control and Cardiovascular Outcomes Across Cardiovascular-Kidney-Metabolic Syndrome Stages: A Post Hoc Analysis of the China Rural Hypertension Control Project
Xiaofan Guo, Shiyu Zhou, Jianjun Mu, et al.
Page
of 11